The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis.

In conclusion, this study reveals that the GAS5/miR-217/LHPP pathway reduces NSCLC cisplatin resistance and that LHPP may serve as a potential therapeutic target for NSCLC cisplatin resistance.
PMID: 33418541 [PubMed - as supplied by publisher]

Source: Aging - January 8, 2021 Category: Biomedical Science Authors: Yang X, Meng L, Zhong Y, Hu F, Wang L, Wang M Tags: Aging (Albany NY) Source Type: research